Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M de Bruijn

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Neurology|May 15, 2026
Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia: A Multicenter Prospective Cohort StudyRobin W van Steenhoven, Anna E M Bastiaansen, Jeroen Kerstens, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 28, 2024
Autoimmune Encephalitis and Paraneoplastic Neurologic Syndromes: A Nationwide Study on Epidemiology and Antibody Testing PerformanceJeroen Kerstens, Marco W J Schreurs, Juna M de Vries, et al.
The Lancet Regional Health. Europe|January 5, 2026
Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort studyJuliette Brenner, Anna E M Bastiaansen, Mar Guasp, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Neurology|May 15, 2026
Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia: A Multicenter Prospective Cohort StudyRobin W van Steenhoven, Anna E M Bastiaansen, Jeroen Kerstens, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 28, 2024
Autoimmune Encephalitis and Paraneoplastic Neurologic Syndromes: A Nationwide Study on Epidemiology and Antibody Testing PerformanceJeroen Kerstens, Marco W J Schreurs, Juna M de Vries, et al.
The Lancet Regional Health. Europe|January 5, 2026
Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort studyJuliette Brenner, Anna E M Bastiaansen, Mar Guasp, et al.
Pageof 5